Bristol Myers Squibb Co. Stock Outperforms Competitors Despite Losses On The Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Bristol Myers Squibb Co. (BMY) slid 0.21% to $71.95 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.25% to 3,839.50 and Dow Jones Industrial Average falling 0.22% to 33,147.25. Bristol Myers Squibb Co. closed $9.49 below its 52-week high ($81.44), which the company reached on December 1st.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson (JNJ) fell 0.51% to $176.65, Pfizer Inc. (PFE) fell 0.18% to $51.24, and Abbott Laboratories (ABT) fell 0.47% to $109.79. Trading volume (7.0 M) remained 2.2 million below its 50-day average volume of 9.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled December 30, 2022.
(END) Dow Jones Newswires
December 30, 2022 16:41 ET (21:41 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.